ZEB1 and neoplasm: These data suggest that induction of glycolysis together with inhibition of the cholesterol pathways in squamous PDAC may act as metabolic triggers for the EMT, whereas, once it is established, other factors (GLI1/2 and ZEB1) modulate lineage commitment, cell viability [68], and the acquired tumor resistance to chemotherapy [80].